Showing results (681-690 of 772) with videos related to
Sort By:
Pageof 78
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 18, 2006
Interactions of two major metabolites of prasugrel, a thienopyridine antiplatelet agent, with the cytochromes P450Jessica L Fayer Rehmel, James A Eckstein, Nagy A Farid, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|April 20, 2019
Atopic eczema: burden of disease and individual suffering - results from a large EU study in adultsJ Ring, A Zink, B W M Arents, et al.Allergy|June 11, 2011
Api m 10, a genuine A. mellifera venom allergen, is clinically relevant but underrepresented in therapeutic extractsS Blank, H Seismann, Y Michel, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 19, 2002
Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7J Andrew Williams, Barbara J Ring, Varon E Cantrell, et al.International Journal of Hygiene and Environmental Health|December 25, 2007
Domestic allergens and endotoxin in three hospitals offering in-patient rehabilitation for allergic diseases in the alpine mountain climate of Bavaria - The AURA studyB Eberlein, A F Gulyas, K Schultz, et al.Contact Dermatitis|April 1, 1990
European multicenter study of TRUE Test, Panel 2J D Wilkinson, D P Bruynzeel, G Ducombs, et al.The Journal of Pharmacology and Experimental Therapeutics|February 1, 1996
Identification of the human cytochromes P450 responsible for the in vitro formation of the major oxidative metabolites of the antipsychotic agent olanzapineB J Ring, J Catlow, T J Lindsay, et al.Transplantation|September 27, 1996
Failure patterns of cryopreserved vein grafts in liver transplantationA A Kuang, J F Renz, L D Ferrell, et al.Allergy|July 24, 2009
Efficacy of desloratadine in intermittent allergic rhinitis: a GA(2)LEN studyJ Bousquet, C Bachert, G W Canonica, et al.Allergy|February 9, 2012
Acupuncture compared with oral antihistamine for type I hypersensitivity itch and skin response in adults with atopic dermatitis: a patient- and examiner-blinded, randomized, placebo-controlled, crossover trialF Pfab, M-T Kirchner, J Huss-Marp, et al.Pageof 78